Inflammation-related Markers and Prognosis of Alpha-fetoprotein Producing Gastric Cancer

Overview

Journal World J Gastrointest Oncol

Publisher Baishideng Publishing Group

Date 2024 Oct 1

PMID 39350978

Authors

Lu Zhang

Yan-Ping Chen

Min Ji

Le-Qian Ying

Chun-Chun Huang

Jing-Yi Zhou

Lin Liu

Affiliations

Soon will be listed here.

Abstract

Background: Inflammation-related markers including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI) and prognostic nutritional index (PNI) could reflect tumor immune microenvironment and predict prognosis of cancers. However, it had not been explored in alpha-fetoprotein (AFP) producing gastric cancer (GC).

Aim: To determine the predictive value of inflammation-related peripheral blood markers including as NLR, PLR, MLR, SII, SIRI and PNI in the prognosis of AFP- producing GC (AFPGC). Besides, this study would also compare the differences in tumor immune microenvironment, clinical characteristics and prognosis between AFPGC and AFP- GC patients to improve the understanding of this disease.

Methods: 573 patients enrolled were retrospectively studied. They were divided into AFP+ group (AFP ≥ 20 ng/mL) and AFP- group (AFP < 20 ng/mL), comparing the levels of NLR/PLR/MLR/SII/SIRI/PNI and prognosis. In AFP+ group, the impact of NLR/PLR/MLR/SII/SIRI/PNI and their dynamic changes on prognosis were further explored.

Results: Compared with AFP- patients, AFP+ patients had higher NLR/PLR/MLR/SII/SIRI and lower PNI levels and poorer overall survival (OS). In the AFP+ group, mortality was significantly lower in the lower NLR/PLR/MLR/SII/SIRI group and higher PNI group. Moreover, the dynamic increase (NLR/PLR/MLR/SII/SIRI) or decrease (PNI) was associated with the rise of mortality within 1 year of follow-up.

Conclusion: Compared with AFP- patients, the level of inflammation-related peripheral blood markers significantly increased in AFP+ patients, which was correlated with OS of AFP+ patients. Also, the gradual increase of SII and SIRI was associated with the risk of death within one year in AFP+ patients. AFPGC should be considered as a separate type and distinguished from AFP- GC because of the difference in tumor immune microenvironment. It requires basic experiments and large clinical samples in the future.

References

Fang L, Yan F, Liu C, Chen J, Wang D, Zhang C . Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer. Cancer Res Treat. 2020; 53(1):131-139. PMC: 7811998. DOI: 10.4143/crt.2020.330. View

Romagnoli G, Wiedermann M, Hubner F, Wenners A, Mathiak M, Rocken C . Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study. Int J Mol Sci. 2017; 18(9). PMC: 5618585. DOI: 10.3390/ijms18091936. View

Wang D, Li C, Xu Y, Xing Y, Qu L, Guo Y . Clinicopathological characteristics and prognosis of alpha-fetoprotein positive gastric cancer in Chinese patients. Int J Clin Exp Pathol. 2015; 8(6):6345-55. PMC: 4525844. View

Diem S, Schmid S, Krapf M, Flatz L, Born D, Jochum W . Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer. 2017; 111:176-181. DOI: 10.1016/j.lungcan.2017.07.024. View

Najjar S, Scuteri A, Shetty V, Wright J, Muller D, Fleg J . Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol. 2008; 51(14):1377-83. PMC: 2771854. DOI: 10.1016/j.jacc.2007.10.065. View

Wang Y, Shen L, Jiao X, Zhang X . Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP. World J Gastroenterol. 2018; 24(2):266-273. PMC: 5768945. DOI: 10.3748/wjg.v24.i2.266. View

Reim D, Choi Y, Yoon H, Park B, Eom B, Kook M . Alpha-fetoprotein is a significant prognostic factor for gastric cancer: Results from a propensity score matching analysis after curative resection. Eur J Surg Oncol. 2017; 43(8):1542-1549. DOI: 10.1016/j.ejso.2017.04.005. View

Xiao W, Chen D, Li S, Fu S, Peng B, Liang L . Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis. BMC Cancer. 2014; 14:117. PMC: 4015698. DOI: 10.1186/1471-2407-14-117. View

Mantovani A, Allavena P, Sica A, Balkwill F . Cancer-related inflammation. Nature. 2008; 454(7203):436-44. DOI: 10.1038/nature07205. View

10.

Fromont G, Godet J, Pires C, Yacoub M, Dore B, Irani J . Biological significance of perineural invasion (PNI) in prostate cancer. Prostate. 2011; 72(5):542-8. DOI: 10.1002/pros.21456. View

11.

Duan S, Sun L, Zhang C, Wu L, Nie G, Huang Z . Association of platelet-to-lymphocyte ratio with kidney clinicopathologic features and renal outcomes in patients with diabetic kidney disease. Int Immunopharmacol. 2021; 93:107413. DOI: 10.1016/j.intimp.2021.107413. View

12.

Huang H, Liu Q, Zhu L, Zhang Y, Lu X, Wu Y . Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients with Cervical Cancer. Sci Rep. 2019; 9(1):3284. PMC: 6397230. DOI: 10.1038/s41598-019-39150-0. View

13.

Goodman A, Kato S, Bazhenova L, Patel S, Frampton G, Miller V . Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers. Mol Cancer Ther. 2017; 16(11):2598-2608. PMC: 5670009. DOI: 10.1158/1535-7163.MCT-17-0386. View

14.

Hirahara T, Arigami T, Yanagita S, Matsushita D, Uchikado Y, Kita Y . Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer. BMC Cancer. 2019; 19(1):672. PMC: 6615151. DOI: 10.1186/s12885-019-5903-y. View

15.

He Q, Li L, Ren Q . The Prognostic Value of Preoperative Systemic Inflammatory Response Index (SIRI) in Patients With High-Grade Glioma and the Establishment of a Nomogram. Front Oncol. 2021; 11:671811. PMC: 8162213. DOI: 10.3389/fonc.2021.671811. View

16.

Liu X, Cheng Y, Sheng W, Lu H, Xu Y, Long Z . Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases. J Surg Oncol. 2010; 102(3):249-55. DOI: 10.1002/jso.21624. View

17.

Wang H, Wang Z, Hou Z, Yang X, Zhu K, Cao M . The Neutrophil-to-Lymphocyte Ratio (NLR) Predicts the Prognosis of Unresectable Intermediate and Advanced Hepatocellular Carcinoma Treated with Apatinib. Cancer Manag Res. 2021; 13:6989-6998. PMC: 8434860. DOI: 10.2147/CMAR.S311526. View

18.

Capone M, Giannarelli D, Mallardo D, Madonna G, Festino L, Grimaldi A . Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab. J Immunother Cancer. 2018; 6(1):74. PMC: 6048712. DOI: 10.1186/s40425-018-0383-1. View

19.

Mo S, Zhou Z, Li Y, Hu X, Ma X, Zhang L . Establishment and validation of a novel nomogram incorporating clinicopathological parameters into the TNM staging system to predict prognosis for stage II colorectal cancer. Cancer Cell Int. 2020; 20:285. PMC: 7339452. DOI: 10.1186/s12935-020-01382-w. View

20.

Okadome K, Baba Y, Yagi T, Kiyozumi Y, Ishimoto T, Iwatsuki M . Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer. Ann Surg. 2018; 271(4):693-700. DOI: 10.1097/SLA.0000000000002985. View